Opinion

Video

Clinical Perspectives of KRAS G12C Inhibitors in NSCLC Mutations

Shared insight into the consideration of KRAS G12C inhibitors in treating co-mutations in NSCLC.

Related Videos
2 expert is featured in this series.
2 expert is featured in this series.
2 experts are featured in this series.
2 expert is featured in this series.
2 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.